Are you Dr. Gheuens?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
E/Cls-1017
Boston, MA 02215Phone+1 617-735-4468Fax+1 617-735-4527
Summary
- Dr. Sarah Gheuens, MD is a neurologist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is an Instructor at Beth Israel Deaconess Medical Center.
Education & Training
Vrije Universiteit BrusselsClass of 2004
Certifications & Licensure
MA State Medical License 2011 - 2025
Publications & Presentations
PubMed
- 1 citationsNeuroimaging and pediatric HIV.David Bearden, Sarah Gheuens
Neurology. Clinical Practice. 2019-10-01 - 363 citationsNusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study.Darryl C. De Vivo, Enrico Bertini, Kathryn J. Swoboda, Wuh-Liang Hwu, Thomas O. Crawford
Neuromuscular Disorders. 2019-09-12 - 71 citationsAn Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical TrialsBasil T. Darras, Michelle A. Farrar, Eugenio Mercuri, Richard S. Finkel, Richard Foster
CNS Drugs. 2019-09-01
Press Mentions
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on MitapivatDecember 8th, 2024- Centogene and Agios Expand Rare Blood Disease PartnershipNovember 5th, 2021
- Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin ResponseJune 27th, 2023
- Join now to see all
